OFSEP High Definition Cohort

Active, not recruitingOBSERVATIONAL
Enrollment

2,842

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Multiple Sclerosis
Trial Locations (25)

Unknown

CHU de Besançon, Besançon

CHU de Bordeaux, Bordeaux

CHU de Caen, Caen

CHU de Clermont-Ferrand, Clermont-Ferrand

CHU de Créteil, Créteil

CHU de Dijon, Dijon

CHU de Grenoble, Grenoble

CHU de Lille, Lille

CHU de Limoges, Limoges

CHU de Lyon, Lyon

CHU de Montpellier, Montpellier

CHU de Nancy, Nancy

CHU de Nantes, Nantes

CHU de Nice, Nice

CHU de Nîmes, Nîmes

CHU Pitié-Salpétrière, Paris

CHU Saint-Antoine, Paris

Fondation Rothschild, Paris

CHI de Poissy-Saint-Germain-en-Laye, Poissy

CHU de Poitiers, Poitiers

CHU de Rennes, Rennes

CHU de Strasbourg, Strasbourg

CHU de Toulouse, Toulouse

CHU de Tours, Tours

CHU de Fort-de-France, Fort-de-France

All Listed Sponsors
lead

EDMUS Foundation

OTHER

NCT03603457 - OFSEP High Definition Cohort | Biotech Hunter | Biotech Hunter